Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated autologous stem cell infusions in cirrhosis
ISRCTN91288089Phase 2Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Jul 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Stem Cell Therapies → Cell Therapies
01
Overview
Phase 2, open-label trial of lenograstim and autologous CD133+ cells in Cirrhosis (3 arms), sponsored by University Hospitals Birmingham. Started Jul 2009; status: completed.
02
Drugs
lenograstimautologous CD133+ cells
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ISRCTN91288089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91288089.